Your browser doesn't support javascript.
loading
Correction: Myeloablative conditioning for allo-HSCT in pediatric ALL: FTBI or chemotherapy?-A multicenter EBMT-PDWP study.
Willasch, Andre Manfred; Peters, Christina; Sedlácek, Petr; Dalle, Jean-Hugues; Kitra-Roussou, Vassiliki; Yesilipek, Akif; Wachowiak, Jacek; Lankester, Arjan; Prete, Arcangelo; Hamidieh, Amir Ali; Ifversen, Marianne; Buechner, Jochen; Kriván, Gergely; Hamladji, Rose-Marie; Diaz-de-Heredia, Cristina; Skorobogatova, Elena; Michel, Gérard; Locatelli, Franco; Bertaina, Alice; Veys, Paul; Dupont, Sophie; Or, Reuven; Güngör, Tayfun; Aleinikova, Olga; Sufliarska, Sabina; Sundin, Mikael; Rascon, Jelena; Kaare, Ain; Nemet, Damir; Fagioli, Franca; Klingebiel, Thomas Erich; Styczynski, Jan; Bierings, Marc; Nagy, Kálmán; Abecasis, Manuel; Afanasyev, Boris; Ansari, Marc; Vettenranta, Kim; Alseraihy, Amal; Chybicka, Alicja; Robinson, Stephen; Bertrand, Yves; Kupesiz, Alphan; Ghavamzadeh, Ardeshir; Campos, Antonio; Pichler, Herbert; Dalissier, Arnaud; Labopin, Myriam; Corbacioglu, Selim; Balduzzi, Adriana.
Afiliação
  • Willasch AM; Division for Stem Cell Transplantation and Immunology, Department for Children and Adolescents, University Hospital, Goethe University Frankfurt, Frankfurt, Germany. andre.willasch@kgu.de.
  • Peters C; St. Anna Children's Hospital, Department of Pediatrics, Medical University of Vienna, Vienna, Austria.
  • Sedlácek P; Department of Pediatric Hematology and Oncology, University Hospital Motol, Prague, Czech Republic.
  • Dalle JH; Department of Pediatric Hemato-Immunology, Hôpital Robert Debré and Université de Paris, Paris, France.
  • Kitra-Roussou V; Stem Cell Transplant Unit, Aghia Sophia Children's Hospital, Thivon and Papadiamantopoulou, Athens, Greece.
  • Yesilipek A; Department of Pediatric Hematology and Stem Cell Transplantation Unit, Medicalpark Antalya Hastanesi, Antalya, Turkey.
  • Wachowiak J; Department of Pediatric Oncology, Hematology and Transplantology, University of Medical Sciences, Poznan, Poland.
  • Lankester A; Department of Pediatrics, Leiden University Medical Center, Leiden, The Netherlands.
  • Prete A; Hematology-Oncology Unit "Lalla Seràgnoli", Department of Pediatrics, University of Bologna, Bologna, Italy.
  • Hamidieh AA; Pediatric Cell Therapy Research Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Ifversen M; Department of Pediatrics, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
  • Buechner J; Department of Pediatric Hematology and Oncology, Oslo University Hospital, Oslo, Norway.
  • Kriván G; Department for Pediatric Hematology and Hemopoietic Stem Cell Transplantation, Central Hospital of Southern Pest, National Institute of Hematology and Infectious Diseases, United St. Istvan and St. László Hospital, Budapest, Hungary.
  • Hamladji RM; Centre Pierre et Marie Curie, Service Hématologie Greffe de Moelle, Alger, Algeria.
  • Diaz-de-Heredia C; Servicio de Hematologia y Oncologia Pediátricas, Hospital Universitario Vall d'Hebron, Barcelona, Spain.
  • Skorobogatova E; BMT Department, Russian Children's Hospital, Moscow, Russia.
  • Michel G; Department of Pediatric Hematology and Oncology and Research Unit EA 3279, Timone Enfants Hospital, AP-HM and Aix-Marseille University, Marseille, France.
  • Locatelli F; Dipartimento di Onco-Ematologia e Terapia Cellulare e Genica, IRCCS Ospedale Pediatrico Bambino Gesù, Rome, Italy.
  • Bertaina A; Dipartimento Materno-Infantile e Scienze Urologiche, Sapienza University of Rome, Rome, Italy.
  • Veys P; Dipartimento di Onco-Ematologia e Terapia Cellulare e Genica, IRCCS Ospedale Pediatrico Bambino Gesù, Rome, Italy.
  • Dupont S; Dipartimento Materno-Infantile e Scienze Urologiche, Sapienza University of Rome, Rome, Italy.
  • Or R; Division of Stem Cell Transplantation and Regenerative Medicine, Department of Pediatrics, School of Medicine, Stanford University, Stanford, CA, USA.
  • Güngör T; Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.
  • Aleinikova O; Department of Pediatric Hematology and Oncology, Cliniques Universitaires Saint-Luc, Brussels, Belgium.
  • Sufliarska S; Department of Bone Marrow Transplantation, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
  • Sundin M; Division of Stem Cell Transplantation, Children's Research Center (CRC), University Children's Hospital, Zurich, Switzerland.
  • Rascon J; Republic Clinical Research Centre for Pediatric Oncology and Hematology, Minsk, Belarus.
  • Kaare A; BMT Unit, Department of Pediatric Hematology and Oncology, Comenius University Medical School, Limbová, Bratislava, Slovak Republic.
  • Nemet D; Division of Pediatrics, CLINTEC, Karolinska Institutet and Pediatric Hematology, Immunology and HCT, Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden.
  • Fagioli F; Center of Pediatric Oncology and Hematology, Vilnius University, Vilnius, Lithuania.
  • Klingebiel TE; Tartu University Hospital, Tartu, Estonia.
  • Styczynski J; Department of Haematology, Internal Clinic, University Hospital Centre, Zagreb, Croatia.
  • Bierings M; Paediatric Onco-Haematology, City of Science and Health of Turino, Regina Margherita Children's Hospital, Torino, Italy.
  • Nagy K; Division for Stem Cell Transplantation and Immunology, Department for Children and Adolescents, University Hospital, Goethe University Frankfurt, Frankfurt, Germany.
  • Abecasis M; Department of Pediatric Hematology and Oncology, Collegium Medicum, Nicolaus Copernicus University Torun, Bydgoszcz, Poland.
  • Afanasyev B; BMT-Unit, University Medical Centre Utrecht Pediatrics, Utrecht, The Netherlands.
  • Ansari M; Department of Hematology, Child Welfare Center, Borsod County Teaching Hospital, Miskolc, Hungary.
  • Vettenranta K; Bone Marrow Transplant Program, Instituto Portugues Oncologia, Lisbon, Portugal.
  • Alseraihy A; Raisa Gorbacheva Memorial Research Institute for Pediatric Oncology, Haematology and Transplantation, Saint Petersburg State Medical I.P. Pavlov University, Saint Petersburg, Russia.
  • Chybicka A; Department of Pediatrics, Onco-Hematology Unit, Geneva University Hospital, Geneva University, Geneva, Switzerland.
  • Robinson S; Hospital for Children and Adolescents, University of Helsinki, Helsinki, Finland.
  • Bertrand Y; Department of Pediatric Hematology Oncology, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia.
  • Kupesiz A; Department of Bone Marrow Transplantation, Oncology and Hematology, Cape of Hope Medical Center, Wroclaw Medical University, Wroclaw, Poland.
  • Ghavamzadeh A; University Hospitals Bristol NHS Foundation Trust, Bristol, UK.
  • Campos A; Department of Pediatric Hematology and BMT, IHOP and Claude Bernard University, Lyon, France.
  • Pichler H; Department of Pediatric Hematology-Oncology, School of Medicine, Akdeniz University, Antalya, Turkey.
  • Dalissier A; Hematology-Oncology and BMT Research, Shariati Hospital, Tehran, Iran.
  • Labopin M; Bone Marrow Transplantation Service, Portuguese Institute of Oncology, Porto, Portugal.
  • Corbacioglu S; St. Anna Children's Hospital, Department of Pediatrics, Medical University of Vienna, Vienna, Austria.
  • Balduzzi A; EBMT Paediatric Diseases Working Party, Paris, France.
Bone Marrow Transplant ; 56(10): 2615, 2021 Oct.
Article em En | MEDLINE | ID: mdl-34413474
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2021 Tipo de documento: Article